Total Payments
$369.89
2022 Payments
$14.87
Companies
4
Transactions
24
Medicare Patients
7,183
Medicare Billing
$785,888
Payment Breakdown by Category
Food & Beverage$355.89 (96.2%)
Education$14.00 (3.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $355.89 | 23 | 96.2% |
| Education | $14.00 | 1 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $261.97 | 17 | $0 (2020) |
| Novo Nordisk Inc | $82.62 | 5 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $14.00 | 1 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $11.30 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $14.87 | 1 | Novo Nordisk Inc ($14.87) |
| 2020 | $25.75 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($25.75) |
| 2019 | $73.69 | 5 | Boehringer Ingelheim Pharmaceuticals, Inc. ($59.69) |
| 2018 | $184.60 | 11 | Boehringer Ingelheim Pharmaceuticals, Inc. ($153.11) |
| 2017 | $70.98 | 5 | Novo Nordisk Inc ($36.26) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/04/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Diabetes | ||||||
| 08/10/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: RESPIRATORY | ||||||
| 02/24/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, COMBIVENT RESPIMAT | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: RESPIRATORY | ||||||
| 10/21/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: RESPIRATORY | ||||||
| 09/25/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: RESPIRATORY | ||||||
| 01/23/2019 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Education | In-kind items and services | $14.00 | General |
| Category: DIABETES | ||||||
| 12/07/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: RESPIRATORY | ||||||
| 09/13/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: RESPIRATORY | ||||||
| 08/30/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: RESPIRATORY | ||||||
| 08/01/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Diabetes | ||||||
| 07/25/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: RESPIRATORY | ||||||
| 06/11/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: RESPIRATORY | ||||||
| 04/02/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: RESPIRATORY | ||||||
| 02/28/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Diabetes | ||||||
| 02/01/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: RESPIRATORY | ||||||
| 01/12/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: RESPIRATORY | ||||||
| 12/06/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO (Drug) | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: RESPIRATORY | ||||||
| 10/25/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Diabetes | ||||||
| 07/12/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Diabetes | ||||||
| 07/12/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,782 | 5,053 | $523,815 | $224,506 |
| 2022 | 27 | 1,773 | 4,975 | $448,145 | $201,017 |
| 2021 | 25 | 1,824 | 4,489 | $429,115 | $193,671 |
| 2020 | 26 | 1,804 | 4,205 | $421,090 | $166,694 |
Total Patients
7,183
Total Services
18,722
Medicare Billing
$785,888
Procedure Codes
104
All Medicare Procedures & Services
104 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 318 | 827 | $175,745 | $68,510 | 39.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 21 | 2,220 | $106,800 | $40,911 | 38.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 251 | 251 | $46,375 | $31,465 | 67.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 55 | 55 | $29,450 | $15,559 | 52.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 170 | 252 | $37,160 | $14,933 | 40.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 67 | 95 | $27,700 | $12,090 | 43.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 148 | 152 | $15,200 | $10,913 | 71.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 19 | 23 | $9,460 | $4,918 | 52.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 158 | 162 | $9,045 | $4,771 | 52.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 37 | 82 | $13,110 | $3,831 | 29.2% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 16 | 19 | $5,645 | $2,999 | 53.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 33 | 43 | $5,985 | $1,786 | 29.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 55 | 55 | $2,565 | $1,620 | 63.1% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 43 | 52 | $5,200 | $1,477 | 28.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 113 | 165 | $2,340 | $1,386 | 59.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 41 | 114 | $7,410 | $1,167 | 15.8% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2023 | 12 | 12 | $4,320 | $1,127 | 26.1% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 67 | 114 | $3,505 | $961.40 | 27.4% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 18 | 19 | $2,850 | $955.32 | 33.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 15 | 16 | $3,170 | $946.91 | 29.9% |
| 85610 | Blood test, clotting time | Office | 2023 | 16 | 180 | $2,700 | $756.00 | 28.0% |
| 20551 | Injection into tendon at attachment to bone or muscle | Office | 2023 | 13 | 26 | $3,645 | $674.21 | 18.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 35 | 36 | $2,640 | $311.92 | 11.8% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 22 | 22 | $660.00 | $168.07 | 25.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 14 | 33 | $855.00 | $157.41 | 18.4% |
About Dr. Jeffrey Wells, D.O
Dr. Jeffrey Wells, D.O is a Family Medicine healthcare provider based in Schnecksville, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2011. The National Provider Identifier (NPI) number assigned to this provider is 1669767992.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Wells, D.O has received a total of $369.89 in payments from pharmaceutical and medical device companies, with $14.87 received in 2022. These payments were reported across 24 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($355.89).
As a Medicare-enrolled provider, Wells has provided services to 7,183 Medicare beneficiaries, totaling 18,722 services with total Medicare billing of $785,888. Data is available for 4 years (2020–2023), covering 104 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Schnecksville, PA
- Active Since 06/15/2011
- Last Updated 08/15/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1669767992
Products in Payments
- STIOLTO RESPIMAT (Drug) $207.31
- Victoza (Drug) $52.75
- SPIRIVA RESPIMAT (Drug) $31.24
- Ozempic (Drug) $29.87
- STIOLTO (Drug) $23.42
- TOUJEO (Drug) $14.00
- FARXIGA (Drug) $11.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Schnecksville
Dr. Kenneth Ryder, Md, MD
Family Medicine — Payments: $4,741
Family Medicine $4,741
Amy Gourniak
Family Medicine — Payments: $740.01
Family Medicine $740.01
Dr. Sean Lewis, D.o, D.O
Family Medicine — Payments: $625.97
Family Medicine $625.97
Dr. Susan Kostenblatt, Md, MD
Family Medicine — Payments: $283.90
Family Medicine $283.90
Breanna Henry, Do, DO
Family Medicine — Payments: $115.92
Family Medicine $115.92
Dr. John Farrell, Md, MD
Family Medicine — Payments: $15.26
Family Medicine $15.26